(+)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol analog results in increased expression of TNFRSF10B mRNA, alpha-Tocopherol analog results in increased expression of TNFRSF10B protein CTD PMID:20686688 (+)-alpha-tocopherol multiple interactions EXP 6480464 benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased expression of TNFRSF10B protein] more ... CTD PMID:20686688 (-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of TNFRSF10B mRNA CTD PMID:23649840 (S)-colchicine decreases expression EXP 6480464 Colchicine results in decreased expression of TNFRSF10B mRNA CTD PMID:24211769 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of TNFRSF10B mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19095052 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TNFRSF10B mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide multiple interactions EXP 6480464 Fenretinide promotes the reaction [DDIT3 protein results in increased expression of TNFRSF10B mRNA] CTD PMID:17273769 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of TNFRSF10B mRNA, Fenretinide results in increased expression of TNFRSF10B protein CTD PMID:15735044 , PMID:17273769 4-tert-butylphenol increases expression EXP 6480464 butylphen results in increased expression of TNFRSF10B protein CTD PMID:15816839 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of TNFRSF10B mRNA CTD PMID:23300844 5-fluorouracil multiple interactions EXP 6480464 TNFRSF10B mutant form inhibits the reaction [Fluorouracil results in increased cleavage of CASP3 protein] more ... CTD PMID:17982676 , PMID:26544897 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of TNFRSF10B mRNA, Fluorouracil results in increased expression of TNFRSF10B protein CTD PMID:15585621 more ... 6-bromoindirubin-3'-oxime multiple interactions EXP 6480464 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat inhibits the reaction [TNFRSF10B protein binds to DDX3X protein]], 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat inhibits the reaction [TNFRSF10B protein binds to GSK3B protein]] CTD PMID:28414160 9-cis-retinoic acid increases expression EXP 6480464 Alitretinoin results in increased expression of TNFRSF10B mRNA CTD PMID:16449964 acetylsalicylic acid decreases response to substance EXP 6480464 TNFRSF10B protein results in decreased susceptibility to Aspirin CTD PMID:18483385 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of TNFRSF10B mRNA CTD PMID:20457246 actinomycin D decreases expression EXP 6480464 Dactinomycin results in decreased expression of TNFRSF10B mRNA CTD PMID:15572759 actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] which results in increased expression of TNFRSF10B mRNA], Dactinomycin inhibits the reaction [Celecoxib results in increased expression of TNFRSF10B mRNA] CTD PMID:15572759 , PMID:27222248 adefovir pivoxil increases expression EXP 6480464 adefovir dipivoxil results in increased expression of TNFRSF10B mRNA CTD PMID:25596134 adenine decreases expression EXP 6480464 Adenine results in decreased expression of TNFRSF10B mRNA CTD PMID:24211769 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TNFRSF10B mRNA CTD PMID:21641981 , PMID:28943387 aflatoxin B2 decreases methylation EXP 6480464 aflatoxin B2 results in decreased methylation of TNFRSF10B intron CTD PMID:30157460 all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF10B mRNA CTD PMID:20349282 alvocidib increases expression EXP 6480464 alvocidib results in increased expression of TNFRSF10B CTD PMID:16820931 amiodarone increases expression EXP 6480464 [Amiodarone results in increased expression of DDIT3 mRNA] which results in increased expression of TNFRSF10B mRNA more ... CTD PMID:21292685 amiodarone multiple interactions EXP 6480464 DDIT3 mutant form inhibits the reaction [Amiodarone results in increased expression of TNFRSF10B], Egtazic Acid inhibits the reaction [Amiodarone results in increased expression of TNFRSF10B] CTD PMID:21292685 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [[arsenic trioxide co-treated with Buthionine Sulfoximine] results in increased expression of TNFRSF10B protein], pyrazolanthrone inhibits the reaction [tanshinone results in increased expression of TNFRSF10B protein] CTD PMID:17145888 , PMID:26203587 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of TNFRSF10B mRNA CTD PMID:24449571 apigenin increases expression EXP 6480464 Apigenin results in increased expression of TNFRSF10B mRNA, Apigenin results in increased expression of TNFRSF10B protein CTD PMID:29247770 aripiprazole multiple interactions EXP 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF10B mRNA CTD PMID:31476115 arsane multiple interactions EXP 6480464 [Arsenic co-treated with Fluorides] results in increased expression of TNFRSF10B mRNA CTD PMID:19962721 arsane increases methylation EXP 6480464 Arsenic results in increased methylation of TNFRSF10B gene CTD PMID:24525453 arsenic atom multiple interactions EXP 6480464 [Arsenic co-treated with Fluorides] results in increased expression of TNFRSF10B mRNA CTD PMID:19962721 arsenic atom increases methylation EXP 6480464 Arsenic results in increased methylation of TNFRSF10B gene CTD PMID:24525453 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of TNFRSF10B mRNA CTD PMID:18585952 arsenite(3-) multiple interactions EXP 6480464 XPA protein affects the reaction [arsenite results in increased expression of TNFRSF10B mRNA] CTD PMID:18585952 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of TNFRSF10B more ... CTD PMID:12851490 more ... arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Buthionine Sulfoximine] results in increased expression of TNFRSF10B protein more ... CTD PMID:12851490 more ... arsenous acid affects response to substance EXP 6480464 TNFRSF10B affects the susceptibility to Arsenic Trioxide CTD PMID:18172319 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with caffeic acid phenethyl ester] results in increased expression of TNFRSF10B mRNA more ... CTD PMID:24289642 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:26238291 , PMID:28593498 bepridil increases expression EXP 6480464 Bepridil results in increased expression of TNFRSF10B protein CTD PMID:21292685 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of TNFRSF10B mRNA CTD PMID:30903817 bisphenol F multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TNFRSF10B mRNA CTD PMID:28628672 bortezomib increases response to substance EXP 6480464 TNFRSF10B protein results in increased susceptibility to Bortezomib, TNFRSF10B results in increased susceptibility to Bortezomib CTD PMID:17510429 bortezomib increases localization EXP 6480464 Bortezomib results in increased localization of TNFRSF10B protein CTD PMID:17326159 bortezomib decreases expression EXP 6480464 Bortezomib results in decreased expression of TNFRSF10B protein CTD PMID:19922463 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of TNFRSF10B mRNA, Bortezomib results in increased expression of TNFRSF10B protein CTD PMID:12902978 more ... bortezomib multiple interactions EXP 6480464 [Bortezomib co-treated with arsenic trioxide] results in increased expression of TNFRSF10B protein more ... CTD PMID:12902978 more ... bortezomib affects expression EXP 6480464 Bortezomib affects the expression of TNFRSF10B mRNA CTD PMID:17327374 brefeldin A multiple interactions EXP 6480464 Brefeldin A inhibits the reaction [Bortezomib results in increased localization of TNFRSF10B protein] CTD PMID:17326159 bupropion increases expression EXP 6480464 Bupropion results in increased expression of TNFRSF10B mRNA CTD PMID:21354251 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of TNFRSF10B mRNA CTD PMID:12160620 cantharidin increases expression EXP 6480464 Cantharidin results in increased expression of TNFRSF10B protein CTD PMID:27113412 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of TNFRSF10B mRNA, Capsaicin results in increased expression of TNFRSF10B protein CTD PMID:19502594 , PMID:19939880 capsaicin multiple interactions EXP 6480464 TNFRSF10B mutant form inhibits the reaction [Capsaicin results in increased susceptibility to TNFSF10 protein] CTD PMID:19939880 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of TNFRSF10B mRNA CTD PMID:24752500 , PMID:25979313 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of TNFRSF10B mRNA CTD PMID:20800606 carboplatin multiple interactions EXP 6480464 [Carboplatin co-treated with Chloroquine] results in increased expression of TNFRSF10B protein CTD PMID:27692344 celastrol increases expression EXP 6480464 tripterine results in increased expression of TNFRSF10B mRNA CTD PMID:20605676 celastrol multiple interactions EXP 6480464 TNFRSF10B protein promotes the reaction [[TNFSF10 protein co-treated with tripterine] results in increased cleavage of PARP1 protein], tripterine results in increased expression of and results in increased localization of TNFRSF10B protein CTD PMID:20605676 celecoxib increases expression EXP 6480464 Celecoxib results in increased expression of TNFRSF10B mRNA, Celecoxib results in increased expression of TNFRSF10B protein CTD PMID:15572759 celecoxib affects response to substance EXP 6480464 TNFRSF10B affects the susceptibility to Celecoxib CTD PMID:15572759 celecoxib multiple interactions EXP 6480464 Cycloheximide promotes the reaction [Celecoxib results in increased expression of TNFRSF10B protein] more ... CTD PMID:15572759 chlorambucil affects expression EXP 6480464 Chlorambucil affects the expression of TNFRSF10B protein CTD PMID:14614459 chlorambucil increases expression EXP 6480464 Chlorambucil results in increased expression of TNFRSF10B mRNA, Chlorambucil results in increased expression of TNFRSF10B protein CTD PMID:18092340 chloroacetaldehyde affects expression EXP 6480464 chloroacetaldehyde affects the expression of TNFRSF10B mRNA CTD PMID:25596134 chloroquine multiple interactions EXP 6480464 [Carboplatin co-treated with Chloroquine] results in increased expression of TNFRSF10B protein CTD PMID:27692344 chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of TNFRSF10B mRNA CTD PMID:27793765 chrysin multiple interactions EXP 6480464 [Cisplatin co-treated with chrysin] results in increased expression of TNFRSF10B protein CTD PMID:25770930 cibenzoline increases expression EXP 6480464 cifenline results in increased expression of TNFRSF10B protein CTD PMID:21292685 cidofovir anhydrous affects expression EXP 6480464 Cidofovir affects the expression of TNFRSF10B mRNA CTD PMID:25596134 cisplatin multiple interactions EXP 6480464 [[[Cisplatin co-treated with 2 more ... CTD PMID:20623264 more ... cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of TNFRSF10B mRNA, Cisplatin results in increased expression of TNFRSF10B protein CTD PMID:20623264 more ... cisplatin affects expression EXP 6480464 Cisplatin affects the expression of TNFRSF10B mRNA CTD PMID:23300844 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of TNFRSF10B mRNA CTD PMID:24211769 clodronic acid affects expression EXP 6480464 Clodronic Acid affects the expression of TNFRSF10B mRNA CTD PMID:25596134 cobalt atom multiple interactions EXP 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of TNFRSF10B mRNA CTD PMID:18078969 cobalt dichloride affects expression EXP 6480464 cobaltous chloride affects the expression of TNFRSF10B mRNA alternative form CTD PMID:19320972 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of TNFRSF10B mRNA CTD PMID:19376846 cobalt dichloride multiple interactions EXP 6480464 cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [[PARP1 protein binds to TNFRSF10B promoter] which results in increased expression of TNFRSF10B mRNA]] CTD PMID:19714248 copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of TNFRSF10B mRNA CTD PMID:20971185 copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of TNFRSF10B mRNA CTD PMID:20971185 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of TNFRSF10B mRNA CTD PMID:19549813 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of TNFRSF10B mRNA CTD PMID:18687144 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of TNFRSF10B mRNA CTD PMID:16101141 curcumin increases expression EXP 6480464 Curcumin results in increased expression of TNFRSF10B protein CTD PMID:16613838 , PMID:18226269 curcumin multiple interactions EXP 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of TNFRSF10B protein more ... CTD PMID:18226269 more ... curcumin increases response to substance EXP 6480464 TNFRSF10B protein results in increased susceptibility to Curcumin CTD PMID:16613838 cycloheximide increases expression EXP 6480464 Cycloheximide results in increased expression of TNFRSF10B mRNA CTD PMID:15572759 cycloheximide multiple interactions EXP 6480464 [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with Cycloheximide] more ... CTD PMID:11212279 more ... cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of TNFRSF10B mRNA CTD PMID:20106945 more ... cytarabine multiple interactions EXP 6480464 Cytarabine promotes the reaction [TNFSF10 protein results in increased expression of TNFRSF10B protein] CTD PMID:18549619 cytarabine increases expression EXP 6480464 Cytarabine results in increased expression of TNFRSF10B protein CTD PMID:18549619 dabrafenib multiple interactions EXP 6480464 [KRAS protein affects the susceptibility to dabrafenib] which affects the expression of TNFRSF10B protein CTD PMID:27222248 daunorubicin multiple interactions EXP 6480464 Daunorubicin promotes the reaction [TNFSF10 results in increased expression of TNFRSF10B mRNA] CTD PMID:17204177 depsipeptide increases expression EXP 6480464 Depsipeptides results in increased expression of TNFRSF10B protein CTD PMID:16849582 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TNFRSF10B mRNA CTD PMID:28628672 diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of TNFRSF10B protein CTD PMID:28571773 diallyl trisulfide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased expression of TNFRSF10B protein] CTD PMID:28571773 diarsenic trioxide affects response to substance EXP 6480464 TNFRSF10B affects the susceptibility to Arsenic Trioxide CTD PMID:18172319 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of TNFRSF10B more ... CTD PMID:12851490 more ... diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Buthionine Sulfoximine] results in increased expression of TNFRSF10B protein more ... CTD PMID:12851490 more ... dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Ursodeoxycholic Acid results in increased expression of TNFRSF10B] CTD PMID:21362627 diclofenac affects expression EXP 6480464 Diclofenac affects the expression of TNFRSF10B mRNA CTD PMID:24752500 dimethylarsinous acid increases expression EXP 6480464 dimethylarsinous acid results in increased expression of TNFRSF10B mRNA CTD PMID:20886546 dioscin increases expression EXP 6480464 dioscin results in increased expression of TNFRSF10B mRNA CTD PMID:29990575 dioxygen multiple interactions EXP 6480464 3 more ... CTD PMID:23452621 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of TNFRSF10B mRNA CTD PMID:23452621 , PMID:25596134 docebenone increases expression EXP 6480464 2 more ... CTD PMID:17645780 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF10B mRNA CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 [[[Doxorubicin co-treated with 2 more ... CTD PMID:19714248 , PMID:21214929 doxorubicin affects response to substance EXP 6480464 TNFRSF10B protein affects the susceptibility to Doxorubicin CTD PMID:16098063 , PMID:17922852 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of TNFRSF10B mRNA, Doxorubicin results in increased expression of TNFRSF10B protein CTD PMID:15897917 more ... DuP 697 increases expression EXP 6480464 DuP 697 results in increased expression of TNFRSF10B protein CTD PMID:15572759 elemental selenium increases expression EXP 6480464 Selenium results in increased expression of TNFRSF10B protein CTD PMID:12432279 embelin increases expression EXP 6480464 embelin results in increased expression of TNFRSF10B protein CTD PMID:24694877 epichlorohydrin increases expression EXP 6480464 Epichlorohydrin results in increased expression of TNFRSF10B mRNA CTD PMID:22723965 epoxomicin increases expression EXP 6480464 epoxomicin results in increased expression of TNFRSF10B protein CTD PMID:17510429 ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of TNFRSF10B mRNA CTD PMID:23649840 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions EXP 6480464 Egtazic Acid inhibits the reaction [Amiodarone results in increased expression of TNFRSF10B] CTD PMID:21292685 etoposide multiple interactions EXP 6480464 Etoposide promotes the reaction [TP53 protein binds to TNFRSF10B promoter] CTD PMID:15964798 etoposide increases expression EXP 6480464 Etoposide results in increased expression of TNFRSF10B mRNA CTD PMID:15964798 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of TNFRSF10B mRNA CTD PMID:25596134 folic acid affects expression EXP 6480464 Folic Acid affects the expression of TNFRSF10B mRNA CTD PMID:16361273 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of TNFRSF10B mRNA CTD PMID:23649840 gemcitabine increases expression EXP 6480464 gemcitabine results in increased expression of TNFRSF10B protein CTD PMID:17671697 gemcitabine multiple interactions EXP 6480464 [gemcitabine co-treated with TNFRSF10B] affects the activity of CASP3 protein, [gemcitabine co-treated with TNFRSF10B] affects the activity of CASP8 protein CTD PMID:18089714 genistein decreases expression EXP 6480464 Genistein results in decreased expression of TNFRSF10B mRNA CTD PMID:16705744 genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of TNFRSF10B mRNA] CTD PMID:23452621 genistein increases expression EXP 6480464 Genistein results in increased expression of TNFRSF10B mRNA CTD PMID:26865667 gingerol increases expression EXP 6480464 gingerol results in increased expression of TNFRSF10B protein CTD PMID:25034532 gingerol multiple interactions EXP 6480464 TP53 protein affects the reaction [gingerol results in increased expression of TNFRSF10B protein] CTD PMID:25034532 glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [rosiglitazone results in increased expression of TNFRSF10B protein] CTD PMID:18164688 Goe 6976 decreases expression EXP 6480464 Go 6976 results in decreased expression of TNFRSF10B protein CTD PMID:17548900 Goe 6976 multiple interactions EXP 6480464 Go 6976 inhibits the reaction [Quercetin results in increased expression of TNFRSF10B protein] CTD PMID:17548900 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of TNFRSF10B CTD PMID:18687144 hydroquinone decreases expression EXP 6480464 hydroquinone results in decreased expression of TNFRSF10B mRNA CTD PMID:15452088 hydroxyurea increases expression EXP 6480464 Hydroxyurea results in increased expression of TNFRSF10B mRNA CTD PMID:18647660 ifosfamide increases expression EXP 6480464 Ifosfamide results in increased expression of TNFRSF10B mRNA CTD PMID:25596134 Ilimaquinone multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10B mRNA] more ... CTD PMID:24930757 Ilimaquinone increases expression EXP 6480464 ilimaquinone results in increased expression of TNFRSF10B mRNA, ilimaquinone results in increased expression of TNFRSF10B protein CTD PMID:24930757 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TNFRSF10B mRNA CTD PMID:28628672 isoalantolactone increases expression EXP 6480464 isoalantolactone results in increased expression of TNFRSF10B protein CTD PMID:29800641 isoalantolactone increases response to substance EXP 6480464 TNFRSF10B protein results in increased susceptibility to isoalantolactone CTD PMID:29800641 isoalantolactone multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [isoalantolactone results in increased expression of TNFRSF10B protein] more ... CTD PMID:29800641 leptomycin B increases expression EXP 6480464 leptomycin B results in increased expression of TNFRSF10B mRNA CTD PMID:20803015 LY294002 increases expression EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10B, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10B protein CTD PMID:15942663 more ... LY294002 multiple interactions EXP 6480464 resveratrol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10B protein] CTD PMID:21179458 masoprocol increases expression EXP 6480464 Masoprocol results in increased expression of TNFRSF10B mRNA, Masoprocol results in increased expression of TNFRSF10B protein CTD PMID:17645780 metformin multiple interactions EXP 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of TNFRSF10B mRNA CTD PMID:29309887 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of TNFRSF10B mRNA, Methotrexate results in increased expression of TNFRSF10B protein CTD PMID:17637740 more ... methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of TNFRSF10B mRNA CTD PMID:24449571 methyl beta-cyclodextrin multiple interactions EXP 6480464 methyl-beta-cyclodextrin inhibits the reaction [Ursodeoxycholic Acid results in increased expression of TNFRSF10B] CTD PMID:21362627 methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of TNFRSF10B mRNA CTD PMID:23649840 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of TNFRSF10B mRNA CTD PMID:23179753 , PMID:28001369 morin increases expression EXP 6480464 morin results in increased expression of TNFRSF10B mRNA CTD PMID:28689916 motexafin gadolinium increases expression EXP 6480464 motexafin gadolinium results in increased expression of TNFRSF10B mRNA CTD PMID:16357179 motexafin gadolinium multiple interactions EXP 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TNFRSF10B mRNA CTD PMID:16357179 N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide increases expression EXP 6480464 N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide results in increased expression of TNFRSF10B protein CTD PMID:15520213 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5 more ... CTD PMID:21362627 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TNFRSF10B protein CTD PMID:16287099 , PMID:17510429 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of TNFRSF10B mRNA CTD PMID:24810058 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of TNFRSF10B protein CTD PMID:17849272 Nodularin multiple interactions EXP 6480464 sauchinone inhibits the reaction [nodularin results in increased expression of TNFRSF10B mRNA] CTD PMID:27061667 Nodularin increases expression EXP 6480464 nodularin results in increased expression of TNFRSF10B mRNA CTD PMID:27061667 Nonidet P-40 increases expression EXP 6480464 Nonidet P-40 results in increased expression of TNFRSF10B mRNA CTD PMID:26552463 NS-398 multiple interactions EXP 6480464 [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with Cycloheximide] more ... CTD PMID:18222423 NS-398 increases expression EXP 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of TNFRSF10B protein CTD PMID:15572759 Nutlin-3 increases expression EXP 6480464 nutlin 3 results in increased expression of TNFRSF10B mRNA, nutlin 3 results in increased expression of TNFRSF10B protein CTD PMID:16439677 , PMID:18092340 nystatin multiple interactions EXP 6480464 Nystatin inhibits the reaction [Quercetin affects the localization of TNFRSF10B protein] CTD PMID:17876056 o-anisidine affects expression EXP 6480464 2-anisidine affects the expression of TNFRSF10B mRNA CTD PMID:28089782 olaparib increases expression EXP 6480464 olaparib results in increased expression of TNFRSF10B protein CTD PMID:25531448 olaparib multiple interactions EXP 6480464 [TNFSF10 protein co-treated with olaparib] results in increased expression of TNFRSF10B protein, DDIT3 protein affects the reaction [[TNFSF10 protein co-treated with olaparib] results in increased expression of TNFRSF10B protein] CTD PMID:25531448 osthole increases expression EXP 6480464 osthol results in increased expression of TNFRSF10B protein CTD PMID:29319219 ozone multiple interactions EXP 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF10B mRNA CTD PMID:31476115 ozone increases expression EXP 6480464 Ozone results in increased expression of TNFRSF10B mRNA CTD PMID:27206323 , PMID:31476115 p-menthan-3-ol decreases expression EXP 6480464 Menthol results in decreased expression of TNFRSF10B mRNA CTD PMID:26760959 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of TNFRSF10B protein CTD PMID:11212279 paclitaxel multiple interactions EXP 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of TNFRSF10B mRNA, Cycloheximide inhibits the reaction [Paclitaxel results in increased expression of TNFRSF10B protein] CTD PMID:11212279 , PMID:29309887 panobinostat multiple interactions EXP 6480464 manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [panobinostat promotes the reaction [resveratrol results in increased expression of TNFRSF10B protein]], panobinostat promotes the reaction [resveratrol results in increased expression of TNFRSF10B protein] CTD PMID:22923501 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of TNFRSF10B mRNA CTD PMID:22230336 , PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of TNFRSF10B mRNA CTD PMID:18836921 , PMID:28414160 paraquat multiple interactions EXP 6480464 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat inhibits the reaction [TNFRSF10B protein binds to DDX3X protein]] more ... CTD PMID:28414160 pemetrexed multiple interactions EXP 6480464 DDIT3 mutant form inhibits the reaction [Pemetrexed results in increased expression of TNFRSF10B] CTD PMID:21726997 pemetrexed increases expression EXP 6480464 Pemetrexed results in increased expression of TNFRSF10B CTD PMID:21726997 Pentoxifylline increases expression EXP 6480464 Pentoxifylline results in increased expression of TNFRSF10B protein CTD PMID:20804743 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of TNFRSF10B protein CTD PMID:26879310 phenethyl caffeate multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with caffeic acid phenethyl ester] results in increased expression of TNFRSF10B mRNA CTD PMID:24289642 phenylarsine oxide multiple interactions EXP 6480464 oxophenylarsine promotes the reaction [Viper Venoms results in increased expression of TNFRSF10B protein], Viper Venoms promotes the reaction [oxophenylarsine results in increased expression of TNFRSF10B protein] CTD PMID:25417048 phenylarsine oxide increases expression EXP 6480464 oxophenylarsine results in increased expression of TNFRSF10B protein CTD PMID:25417048 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of TNFRSF10B mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF10B mRNA CTD PMID:27188386 propanal increases expression EXP 6480464 propionaldehyde results in increased expression of TNFRSF10B mRNA CTD PMID:26079696 propylparaben increases expression EXP 6480464 propylparaben results in increased expression of TNFRSF10B mRNA CTD PMID:24481588 quercetin affects localization EXP 6480464 Quercetin affects the localization of TNFRSF10B protein CTD PMID:17876056 quercetin increases expression EXP 6480464 Quercetin results in increased expression of TNFRSF10B mRNA, Quercetin results in increased expression of TNFRSF10B protein CTD PMID:17548900 more ... quercetin multiple interactions EXP 6480464 [TNFSF10 protein co-treated with Quercetin] results in increased expression of TNFRSF10B protein more ... CTD PMID:17548900 more ... resorcinol decreases expression EXP 6480464 resorcinol results in decreased expression of TNFRSF10B mRNA CTD PMID:22623647 resveratrol multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with resveratrol] results in increased expression of TNFRSF10B mRNA more ... CTD PMID:18222423 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of TNFRSF10B mRNA, resveratrol results in increased expression of TNFRSF10B protein CTD PMID:12569576 more ... resveratrol increases localization EXP 6480464 resveratrol results in increased localization of TNFRSF10B protein CTD PMID:19561642 rottlerin multiple interactions EXP 6480464 rottlerin inhibits the reaction [Ursodeoxycholic Acid results in increased expression of TNFRSF10B] CTD PMID:21362627 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 [arsenic trioxide co-treated with Buthionine Sulfoximine] results in increased expression of TNFRSF10B protein, pyrazolanthrone inhibits the reaction [[arsenic trioxide co-treated with Buthionine Sulfoximine] results in increased expression of TNFRSF10B protein] CTD PMID:17145888 salubrinal multiple interactions EXP 6480464 salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased expression of TNFRSF10B protein] CTD PMID:20686688 sanguinarine multiple interactions EXP 6480464 [sanguinarine co-treated with arsenic trioxide] results in increased expression of TNFRSF10B mRNA, [sanguinarine co-treated with arsenic trioxide] results in increased expression of TNFRSF10B protein CTD PMID:24345465 SB 431542 increases expression EXP 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of TNFRSF10B protein CTD PMID:25670856 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF10B mRNA CTD PMID:27188386 SC-58125 increases expression EXP 6480464 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole results in increased expression of TNFRSF10B protein CTD PMID:15572759 selenium atom increases expression EXP 6480464 Selenium results in increased expression of TNFRSF10B protein CTD PMID:12432279 selumetinib multiple interactions EXP 6480464 AZD 6244 inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of CASP3 protein]] more ... CTD PMID:27222248 silibinin increases expression EXP 6480464 Silybin results in increased expression of TNFRSF10B CTD PMID:19939880 silibinin multiple interactions EXP 6480464 DDIT3 affects the reaction [Silybin results in increased expression of TNFRSF10B] CTD PMID:19939880 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of TNFRSF10B mRNA CTD PMID:25351596 silver atom increases expression EXP 6480464 Silver results in increased expression of TNFRSF10B mRNA CTD PMID:28959546 silver(0) increases expression EXP 6480464 Silver results in increased expression of TNFRSF10B mRNA CTD PMID:28959546 sodium arsenite multiple interactions EXP 6480464 [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with Cycloheximide] more ... CTD PMID:15741166 , PMID:18222423 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of TNFRSF10B mRNA CTD PMID:15741166 sorafenib increases expression EXP 6480464 sorafenib results in increased expression of TNFRSF10B mRNA, sorafenib results in increased expression of TNFRSF10B protein CTD PMID:21601561 sulforaphane increases expression EXP 6480464 sulforafan results in increased expression of TNFRSF10B mRNA, sulforafan results in increased expression of TNFRSF10B protein CTD PMID:26833863 , PMID:29792947 sulforaphane multiple interactions EXP 6480464 [sulforafan co-treated with TNFSF10 protein] results in increased expression of TNFRSF10B protein CTD PMID:29792947 sulindac increases expression EXP 6480464 Sulindac results in increased expression of TNFRSF10B protein CTD PMID:15572759 sulindac sulfide multiple interactions EXP 6480464 sulindac sulfide inhibits the reaction [PTGS2 protein results in decreased expression of TNFRSF10B mRNA] CTD PMID:12208739 sulindac sulfide increases expression EXP 6480464 sulindac sulfide results in increased expression of TNFRSF10B mRNA, sulindac sulfide results in increased expression of TNFRSF10B protein CTD PMID:11559570 more ... sulindac sulfone increases expression EXP 6480464 sulindac sulfone results in increased expression of TNFRSF10B mRNA CTD PMID:11559570 sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of TNFRSF10B mRNA CTD PMID:31533062 thalidomide decreases expression EXP 6480464 Thalidomide results in decreased expression of TNFRSF10B protein CTD PMID:16531263 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of TNFRSF10B mRNA CTD PMID:22378314 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of TNFRSF10B mRNA, trichostatin A results in increased expression of TNFRSF10B protein CTD PMID:15964798 trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of TNFRSF10B mRNA CTD PMID:28542535 trichostatin A multiple interactions EXP 6480464 [Plant Extracts co-treated with trichostatin A] results in increased expression of TNFRSF10B protein more ... CTD PMID:18709356 , PMID:30958996 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of TNFRSF10B protein CTD PMID:16820965 Tungsten carbide multiple interactions EXP 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of TNFRSF10B mRNA CTD PMID:18078969 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of TNFRSF10B mRNA CTD PMID:22378314 Tylophorine increases expression EXP 6480464 tylophorine analog results in increased expression of TNFRSF10B mRNA CTD PMID:19284764 ursodeoxycholic acid multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Ursodeoxycholic Acid results in increased expression of TNFRSF10B] more ... CTD PMID:21362627 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of TNFRSF10B mRNA, Ursodeoxycholic Acid results in increased expression of TNFRSF10B protein CTD PMID:21362627 ursodeoxycholic acid increases response to substance EXP 6480464 TNFRSF10B results in increased susceptibility to Ursodeoxycholic Acid CTD PMID:21362627 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of TNFRSF10B gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of TNFRSF10B mRNA CTD PMID:15964798 , PMID:29154799 vemurafenib multiple interactions EXP 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of TNFRSF10B protein more ... CTD PMID:27169980 , PMID:27222248 venom increases expression EXP 6480464 Viper Venoms results in increased expression of TNFRSF10B protein CTD PMID:25417048 venom multiple interactions EXP 6480464 oxophenylarsine promotes the reaction [Viper Venoms results in increased expression of TNFRSF10B protein] more ... CTD PMID:25417048 vincristine increases expression EXP 6480464 Vincristine results in increased expression of TNFRSF10B mRNA CTD PMID:23649840 vismodegib multiple interactions EXP 6480464 [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10B protein] CTD PMID:22087285 vismodegib increases expression EXP 6480464 HhAntag691 results in increased expression of TNFRSF10B protein CTD PMID:22087285 vitamin E multiple interactions EXP 6480464 benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased expression of TNFRSF10B protein] more ... CTD PMID:20686688 vitamin E increases expression EXP 6480464 alpha-Tocopherol analog results in increased expression of TNFRSF10B mRNA, alpha-Tocopherol analog results in increased expression of TNFRSF10B protein CTD PMID:20686688 vorinostat multiple interactions EXP 6480464 [Vorinostat co-treated with Quercetin] results in increased expression of TNFRSF10B protein more ... CTD PMID:19509267 , PMID:30958996 vorinostat increases expression EXP 6480464 vorinostat results in increased expression of TNFRSF10B mRNA, vorinostat results in increased expression of TNFRSF10B protein CTD PMID:19509267 more ... zinc acetate increases expression EXP 6480464 Zinc Acetate results in increased expression of TNFRSF10B mRNA CTD PMID:16357179 zinc acetate multiple interactions EXP 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TNFRSF10B mRNA CTD PMID:16357179 zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of TNFRSF10B mRNA CTD PMID:18593933 zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of TNFRSF10B mRNA CTD PMID:18593933 zoledronic acid multiple interactions EXP 6480464 [Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF10B mRNA CTD PMID:20349282
Gene-Chemical Interaction Annotations
